JP2024543158A5 - - Google Patents
Info
- Publication number
- JP2024543158A5 JP2024543158A5 JP2024531308A JP2024531308A JP2024543158A5 JP 2024543158 A5 JP2024543158 A5 JP 2024543158A5 JP 2024531308 A JP2024531308 A JP 2024531308A JP 2024531308 A JP2024531308 A JP 2024531308A JP 2024543158 A5 JP2024543158 A5 JP 2024543158A5
- Authority
- JP
- Japan
- Prior art keywords
- ligand
- binding molecule
- amino acid
- pdgf
- vegf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2021/132735 WO2023092324A1 (zh) | 2021-11-24 | 2021-11-24 | 多特异性配体结合分子及其应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024543158A JP2024543158A (ja) | 2024-11-19 |
| JP2024543158A5 true JP2024543158A5 (https=) | 2024-12-02 |
Family
ID=86538655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024531308A Withdrawn JP2024543158A (ja) | 2021-11-24 | 2021-11-24 | 多重特異性リガンド結合分子及びその用途 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20250002557A1 (https=) |
| EP (1) | EP4438629A1 (https=) |
| JP (1) | JP2024543158A (https=) |
| WO (1) | WO2023092324A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116162148B (zh) * | 2021-11-24 | 2025-09-09 | 中山光度生物医药有限公司 | 多特异性配体结合分子及其应用 |
| CN120536440A (zh) * | 2025-05-23 | 2025-08-26 | 中山大学中山眼科中心 | 一种靶向pdgf-c抑制纤维化的核酸适配子及其应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE30985E (en) | 1978-01-01 | 1982-06-29 | Serum-free cell culture media | |
| US4560655A (en) | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
| US4657866A (en) | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
| US4767704A (en) | 1983-10-07 | 1988-08-30 | Columbia University In The City Of New York | Protein-free culture medium |
| GB8516415D0 (en) | 1985-06-28 | 1985-07-31 | Celltech Ltd | Culture of animal cells |
| US4927762A (en) | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
| ATE135397T1 (de) | 1988-09-23 | 1996-03-15 | Cetus Oncology Corp | Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte |
| US5122469A (en) | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| CN101433715B (zh) | 1999-06-08 | 2013-04-17 | 里珍纳龙药品有限公司 | 具有改善的药物动力学特性的修饰嵌合多肽 |
| WO2015123715A1 (en) | 2014-02-21 | 2015-08-27 | Vegenics Pty Limited | Ligand binding molecules and uses thereof |
-
2021
- 2021-11-24 EP EP21965062.9A patent/EP4438629A1/en not_active Withdrawn
- 2021-11-24 JP JP2024531308A patent/JP2024543158A/ja not_active Withdrawn
- 2021-11-24 WO PCT/CN2021/132735 patent/WO2023092324A1/zh not_active Ceased
- 2021-11-24 US US18/713,012 patent/US20250002557A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11738064B2 (en) | Pharmaceutical composition for preventing and treating eye diseases, containing as active ingredient, fusion protein in which tissue-penetrating peptide and anti-vascular endothelial growth factor preparation are fused | |
| JP5954990B2 (ja) | Vegf−aレセプター相互作用を阻害する結合タンパク質 | |
| AU2006227571B2 (en) | Novel anti-PlGF antibody | |
| US20220096596A1 (en) | Method of treating amd in patients refractory to anti-vegf therapy | |
| US8710187B2 (en) | Modified binding proteins inhibiting the VEGF-A receptor interaction | |
| CN117467025B (zh) | 一种抗vegf和补体双功能融合蛋白及其应用 | |
| US20220175881A1 (en) | Method of treating conditions of the eye with an anti-vegf darpin | |
| CN107312093A (zh) | 血管内皮生长因子融合蛋白 | |
| JP2021511030A5 (https=) | ||
| JP2024543158A5 (https=) | ||
| CN109310779A (zh) | 缀合的c1酯酶抑制剂及其用途 | |
| JP2024543158A (ja) | 多重特異性リガンド結合分子及びその用途 | |
| US20160009776A1 (en) | Pdgfrbeta-fc fusion proteins and uses thereof | |
| WO2016005381A1 (en) | Pdgfrbeta-fc fusion proteins and uses thereof | |
| CN121517576A (zh) | 能够结合VEGF的Fc融合蛋白及其用途 | |
| HK1238258A1 (en) | Binding proteins inhibiting the vegf-a receptor interaction | |
| HK1179876B (en) | Modified binding proteins inhibiting the vegf-a receptor interaction | |
| HK1179876A (en) | Modified binding proteins inhibiting the vegf-a receptor interaction | |
| HK1161726A (en) | Binding proteins inhibiting the vegf-a receptor interaction |